CIBC Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.3M Buy
371,626
+5,659
+2% +$453K 0.06% 225
2025
Q4
$34.9M Buy
365,967
+144,369
+65% +$14.2M 0.08% 163
2025
Q3
$21.6M Buy
221,598
+334
+0.2% +$34.6K 0.06% 197
2025
Q2
$23.8M Sell
221,264
-18,850
-8% -$1.91M 0.07% 180
2025
Q1
$24.2M Sell
240,114
-2,371
-1% -$239K 0.08% 167
2024
Q4
$21.7M Buy
242,485
+10,181
+4% +$896K 0.07% 181
2024
Q3
$19.5M Buy
232,304
+16,037
+7% +$1.26M 0.06% 187
2024
Q2
$16.7M Sell
216,267
-9,397
-4% -$688K 0.06% 194
2024
Q1
$15.5M Buy
225,664
+1,576
+0.7% +$101K 0.05% 211
2023
Q4
$13M Sell
224,088
-9,425
-4% -$503K 0.05% 219
2023
Q3
$12.3M Buy
233,513
+174
+0.1% +$9.13K 0.05% 208
2023
Q2
$12.6M Sell
233,339
-11,667
-5% -$609K 0.05% 207
2023
Q1
$12.3M Buy
245,006
+5,039
+2% +$237K 0.05% 209
2022
Q4
$11.1M Buy
239,967
+13,225
+6% +$573K 0.05% 215
2022
Q3
$8.78M Buy
226,742
+16,732
+8% +$671K 0.04% 244
2022
Q2
$7.83M Buy
210,010
+46,340
+28% +$1.89M 0.03% 247
2022
Q1
$7.25M Buy
163,670
+2,013
+1% +$87.2K 0.03% 294
2021
Q4
$6.87M Buy
161,657
+7,120
+5% +$299K 0.03% 323
2021
Q3
$6.71M Buy
154,537
+4,044
+3% +$179K 0.03% 300
2021
Q2
$6.43M Buy
150,493
+3,276
+2% +$138K 0.03% 306
2021
Q1
$5.69M Buy
147,217
+7,440
+5% +$282K 0.02% 310
2020
Q4
$5.03M Sell
139,777
-429
-0.3% -$15.5K 0.02% 312
2020
Q3
$5.36M Buy
140,206
+8,557
+6% +$330K 0.03% 274
2020
Q2
$4.62M Buy
131,649
+11,473
+10% +$413K 0.03% 275
2020
Q1
$3.92M Sell
120,176
-542
-0.4% -$21.2K 0.03% 264
2019
Q4
$5.46M Sell
120,718
-443
-0.4% -$18.5K 0.03% 241
2019
Q3
$4.93M Sell
121,161
-1,141
-0.9% -$48.3K 0.03% 244
2019
Q2
$5.26M Sell
122,302
-1,896
-2% -$72.9K 0.03% 235
2019
Q1
$4.77M Sell
124,198
-8,614
-6% -$329K 0.03% 239
2018
Q4
$4.69M Sell
132,812
-4,064
-3% -$147K 0.03% 203
2018
Q3
$5.27M Sell
136,876
-1,706
-1% -$59.6K 0.03% 210
2018
Q2
$4.53M Buy
138,582
+4,961
+4% +$150K 0.03% 232
2018
Q1
$3.65M Sell
133,621
-6,307
-5% -$171K 0.02% 269
2017
Q4
$3.47M Buy
139,928
+6,751
+5% +$186K 0.02% 289
2017
Q3
$3.88M Buy
133,177
+3,324
+3% +$91.8K 0.02% 263
2017
Q2
$3.6M Buy
129,853
+689
+0.5% +$18.3K 0.02% 266
2017
Q1
$3.21M Buy
129,164
+248
+0.2% +$6.03K 0.02% 292
2016
Q4
$2.79M Buy
128,916
+9,358
+8% +$204K 0.02% 312
2016
Q3
$2.85M Sell
119,558
-9,956
-8% -$238K 0.02% 308
2016
Q2
$3.03M Buy
129,514
+2,433
+2% +$52.6K 0.02% 289
2016
Q1
$2.39M Buy
127,081
+2,556
+2% +$44.9K 0.02% 331
2015
Q4
$2.3M Sell
124,525
-9,822
-7% -$176K 0.02% 325
2015
Q3
$2.21M Buy
134,347
+1,505
+1% +$25.7K 0.02% 335
2015
Q2
$2.35M Buy
132,842
+5,836
+5% +$104K 0.02% 343
2015
Q1
$2.25M Sell
127,006
-2,338
-2% -$37K 0.02% 349
2014
Q4
$1.71M Sell
129,344
-34,027
-21% -$435K 0.01% 404
2014
Q3
$1.93M Sell
163,371
-14,097
-8% -$178K 0.01% 411
2014
Q2
$2.27M Sell
177,468
-2,365
-1% -$30.8K 0.01% 382
2014
Q1
$2.43M Sell
179,833
-8,434
-4% -$111K 0.01% 366
2013
Q4
$2.26M Sell
188,267
-7,812
-4% -$92.3K 0.01% 363
2013
Q3
$2.3M Sell
196,079
-14,131
-7% -$153K 0.01% 343
2013
Q2
$1.95M Buy
+210,210
New +$1.78M 0.01% 371

Other funds holding BSX